Year: 2025
Type: article
Study design: Case Report
Abstract: Immunotherapy-related adverse events arise from the disinhibition of the body's own immune system. A 76-year-old Caucasian man undergoing treatment with nivolumab monotherapy for metastatic clear cell renal carcinoma presented to our hospital with symptoms of fatigue and easy bruising. Laboratory analysis confirmed warm autoimmune hemolytic anemia with pancytopenia. Bone marrow biopsy demonstrated no evidence of malignancy or marrow failure. He was initiated on guideline-driven therapy with corticosteroids and experienced complete resolution of cytopenias by the three-month follow-up.
Source: Cureus
DOI: 10.7759/cureus.92951
Authors: Matthew Baron, Fnu Amisha, Kiranpreet Kaur, Neha Verma
Institutions: Moffitt Cancer Center, University of South Florida
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4414402212